Podcast: Generic Biologics

A Senate committee has approved legislation to create an FDA regulatory pathway for generic biologics. Mary Agnes Carey, associate editor of CQ HealthBeat, comments on this recent activity.
July 5, 2007
Sign up for our eNewsletters
Get the latest news and updates